Skip to search formSkip to main contentSkip to account menu

dironyl

Known as: urea, N,N-diethyl-N'-((8 alpha)-6-methylergolin-8-yl)-, (Z)-2-butenedioate (1:1), transdihydrolisuride, N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Dopamine AgonistsLisuride

Narrower (1)

VUFB 6638
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models.
While dopamine D2 receptor partial agonists (PAs) have been long considered for treating schizophrenia, only one, aripiprazole… 
2009
2009
Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action
2008
2008
Recognition Properties and Competitive Assays of a Dual Dopamine/Serotonin Selective Molecularly Imprinted Polymer
A molecularly imprinted polymer (MIP) with dual dopamine/serotonin-like binding sites (DS-MIP) was synthesized for use as a… 
Highly Cited
2005
Highly Cited
2005
Agonism at 5-HT2B receptors is not a class effect of the ergolines.
1999
1999
Direct resolution of optically active isomers on chiral packings containing ergoline skeleton. 6. Enantioseparation of profens.
The enantioselective behaviour of some underivatized 2-arylpropionic acids (profens) and flobufen by HPLC using a terguride-based… 
1995
1995
Stable expression of human cytochrome P450 3A4 in V79 cells and its application for metabolic profiling of ergot derivatives.
1991
1991
Behavioural profile of partial D2 dopamine receptor agonists
The effects of partial D2 dopamine (DA) receptor agonists on the behavioural activation produced by 1.5 and 8.0 mg/kgd… 
1988
1988
Attenuation of forgetting by pharmacological stimulation of aminergic neurotransmitter systems
1987
1987
Terguride: partial dopamine agonist in the treatment of Parkinson's disease.
In an open trial, 15 patients with PD (mostly stage V) were treated with the partial DA agonist, terguride, a derivative of… 
1986
1986
Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride.
The long term effectiveness and tolerance of terguride, a new ergot derivative, as initial therapy were evaluated in 20 patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)